HERPES ZOSTER (HZ)
Clinical trials for HERPES ZOSTER (HZ) explained in plain language.
Never miss a new study
Get alerted when new HERPES ZOSTER (HZ) trials appear
Sign up with your email to follow new studies for HERPES ZOSTER (HZ), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could an extra shingles shot protect transplant patients?
⭐️ VACCINE ⭐️ Recruiting nowThis study looks at how well the shingles vaccine (Shingrix) works in adults with kidney failure who are waiting for a kidney transplant. Researchers want to see if giving an extra dose after the transplant boosts the immune response. About 132 participants will be followed for u…
Matched conditions: HERPES ZOSTER (HZ)
Phase: PHASE3 • Sponsor: University of Colorado, Denver • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:05 UTC
-
Promising new shingles vaccine enters human trials
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new recombinant shingles vaccine in healthy adults aged 40 and above. Researchers will give two doses and monitor for side effects and immune response. The trial involves 645 participants and compares the new vaccine to an existing one (Shingrix) and placebo.
Matched conditions: HERPES ZOSTER (HZ)
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Institute Of Biological Products • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:08 UTC
-
Shingles may trigger dementia: study probes hidden danger
Knowledge-focused Recruiting nowThis observational study looks at whether people with shingles (herpes zoster) have a higher risk of vascular dementia—memory loss from reduced blood flow to the brain. Researchers will analyze tiny particles called exosomes in blood samples from 375 participants over 12 months. …
Matched conditions: HERPES ZOSTER (HZ)
Sponsor: Center for Clinical Studies, Texas • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC